DIANA HAUSMAN

CIK 1563992 · Chief Medical Officer · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.59M

Companies

4

Total Filings

25

Lifetime Open-Market Net

-$3.21M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMRX Director 5,500 $4.19 $23.0K $19.9K 7 2026-06-11
ZNTL Chief Medical Officer 373,876 $3.75 $1.40M -$42.4K 3 2024-05-09
ZYME Chief Medical Officer 7,377 $22.88 $168.8K -$3.22M 10 2021-03-12
Cascadian Therapeutics, Inc. (ONTY) Delisted Chief Medical Officer 5,747 $26.7K 5 2015-09-28

Recent Filings · Page 3 of 3

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-09-28 Cascadian Therapeutics, Inc. (ONTY) Delisted Grant (A) $0 EDGAR
2015-06-03 Cascadian Therapeutics, Inc. (ONTY) Delisted Buy (P) +5,747 $26.7K EDGAR
2014-12-16 Cascadian Therapeutics, Inc. (ONTY) Delisted Grant (A) $0 EDGAR
2013-12-16 Cascadian Therapeutics, Inc. (ONTY) Delisted Grant (A) $0 EDGAR
2012-12-14 Cascadian Therapeutics, Inc. (ONTY) Delisted Grant (A) $0 EDGAR
Showing 2125 of 25
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.